Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Miguel Ángel Pujana, Zhengcheng He et al.|Nature Communications|2022Cited by 53
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Aslihan Ugun‐Klusek, Simon R. Johnson et al.|EMBO Molecular Medicine|2021Cited by 21
Biological basis of extensive pleiotropy between blood traits and cancer riskMiguel Ángel Pardo-Cea, Miguel Ángel Pujana, Xavier Farré et al.|Genome Medicine|2024Cited by 13
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and TissueRoderic Espín, Miguel Ángel Pujana, Alexandra Baiges et al.|Molecular Cancer Research|2021Cited by 9
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary functionXavier Farré, Miguel Ángel Pujana, Roderic Espín et al.|ERJ Open Research|2021Cited by 3